LATESTSEARCH ⌕
NASDAQ / LIVE COMPANY INTELLIGENCE

Structure Therapeutics Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERGPCR
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / GPCR COVERAGE

What’s moving Structure Therapeutics Inc. now

Current reporting with the operating signal separated from the noise.

01
TradingKey

GPCR|Structure Therapeutics Inc|Price:48.070|Chg%:-1.400

The story matters when it changes Structure Therapeutics Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
02
Structure Therapeutics Inc. ADR

Structure Therapeutics Inc. ADR

The story matters when it changes Structure Therapeutics Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
03
TradingKey

Structure Therapeutics Inc (GPCR) Technical Analysis: Support, Resistance, Indicators & Moving Averages

The story matters when it changes Structure Therapeutics Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
04
TradingView

Price to sales forward of Structure Therapeutics Inc. – NASDAQ:GPCR

The story matters when it changes Structure Therapeutics Inc.’s customers, execution, competitive position or capital requirements.

Watch next: official volume, pricing, inventory and segment margin.
05
TradingKey

Structure Therapeutics Inc (GPCR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

Investors are testing whether Structure Therapeutics Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
06
TradingKey

Structure Therapeutics Inc (GPCR) Balance Sheet

The story matters when it changes Structure Therapeutics Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
07
FMR LLC Discloses Major Beneficial Ownership Changes in Structure Therapeutics Inc.

FMR LLC Discloses Major Beneficial Ownership Changes in Structure Therapeutics Inc.

The story matters when it changes Structure Therapeutics Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
08
Structure Therapeutics Inc. (GPCR) Discusses Positive Topline Results from ACCESS II and Related Studies of Aleniglipron Oral GLP-1 Transcript

Structure Therapeutics Inc. (GPCR) Discusses Positive Topline Results from ACCESS II and Related Studies of Aleniglipron Oral GLP-1 Transcript

The story matters when it changes Structure Therapeutics Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
09
Structure Therapeutics Inc. (GPCR) Eyes Major 2025 Catalyst With Phase 2b Obesity Data

Structure Therapeutics Inc. (GPCR) Eyes Major 2025 Catalyst With Phase 2b Obesity Data

The story matters when it changes Structure Therapeutics Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
10
Structure Therapeutics Inc. Announces Late-Breaking Poster Presentations at the American Diabetes Association 85th Scientific Sessions

Structure Therapeutics Inc. Announces Late-Breaking Poster Presentations at the American Diabetes Association 85th Scientific Sessions

The story matters when it changes Structure Therapeutics Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
11
Why Is Structure Therapeutics Inc. (GPCR) Among the Best Up and Coming Stocks to Buy According to Analysts?

Why Is Structure Therapeutics Inc. (GPCR) Among the Best Up and Coming Stocks to Buy According to Analysts?

Investors are testing whether Structure Therapeutics Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
PRIMARY DOCUMENTS / SEC EDGAR

Latest GPCR filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-05-07 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2025-11-06 · Period 2025-09-30SEC ↗10-KAnnual financial reportFiled 2026-02-26 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-06-18 · Period 2026-06-17SEC ↗8-KMaterial company eventFiled 2026-05-07 · Period 2026-05-07SEC ↗8-KMaterial company eventFiled 2026-04-15 · Period 2026-04-15SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-04-23 · Period 2026-06-17SEC ↗4Official SEC filingFiled 2026-07-24 · Period 2026-07-22SEC ↗
EARNINGS / QUARTERLY TRACKER

Structure Therapeutics Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.